Brief: FDA Issues Warning Letter To Dabur India Dated July 24th
04/08/2026 19:35
BRIEF-FDA Issues Warning Letter To Dabur India Dated July 24th Aug 4 (Reuters) -
FDA: ISSUES WARNING LETTER TO DABUR INDIA
FDA: IN JULY 24 WARNING LETTER, ASKS DABUR TO CORRECT ANY VIOLATIONS PROMPTLY, RESPOND WITHIN 15 WORKING DAYS
FDA: DABUR'S FEB 4 RESPONSE TO FDA, ITS QUALITY SYSTEMS ARE INADEQUATE
Source text: [ID:]
Further company coverage: DABU.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Dabur India
See all newsBrief: Dabur Says India Markets Regulator SEBI Has Issued An Administrative Warning Letter To Co
Dabur India falls on lower-than-expected quarterly margin, long-term CEO resignation
Dabur's global CEO resigns, India boss joins board (updated)
Brief: Dabur Says Mohit Malhotra Resigns As Global CEO And Whole-Time Director Effective November 13, 2026
Dabur India's global CEO Mohit Malhotra resigns